NCT00512928View on ClinicalTrials.gov

Safety Study of Vitamin K2 During Anticoagulation in Human Volunteers

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Healthy
Interventions
DRUG

acenocoumarol

max 5 mg per day during 10 weeks

DIETARY_SUPPLEMENT

menaquinone-7

In successive weeks (6 weeks) the dosage is increased over the range 10 µg to 20 µg increasing to 45 µg MK-7 for the final week.

Trial Locations (1)

6200 MD

Maastricht University, Maastricht

All Listed Sponsors
lead

Maastricht University

OTHER

NCT00512928 - Safety Study of Vitamin K2 During Anticoagulation in Human Volunteers | Biotech Hunter | Biotech Hunter